These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7014985)

  • 1. Immunology of pyelonephritis in the primate model: live versus heat-killed bacteria.
    Roberts JA; Domingue GJ; Martin LN; Kim JC
    Kidney Int; 1981 Feb; 19(2):297-305. PubMed ID: 7014985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology of pyelonephritis in the primate model. II. Effect on immunosuppression.
    Roberts JA; Domingue GJ; Martin LN; Kim JC; Rangan SR
    Invest Urol; 1981 Nov; 19(3):148-53. PubMed ID: 6271703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with a formalin-killed P-fimbriated E. coli whole-cell vaccine prevents renal scarring from pyelonephritis in the non-human primate.
    Roberts JA; Kaack MB; Baskin G; Svenson SB
    Vaccine; 1995 Jan; 13(1):11-6. PubMed ID: 7762266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of experimental pyelonephritis in the monkey.
    Roberts JA; Kaack MB; Baskin G
    J Urol; 1990 Jan; 143(1):150-4. PubMed ID: 2403597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate.
    Roberts JA; Kaack MB; Baskin G; Svenson SB
    Infect Immun; 1993 Dec; 61(12):5214-8. PubMed ID: 8225595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.
    Smith JW; Kaijser B
    J Clin Invest; 1976 Aug; 58(2):276-81. PubMed ID: 783196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of antibody-coated bacteria in urinary sediment in experimental pyelonephritis.
    Smith JW; Jones SR; Kaijser B
    J Infect Dis; 1977 Apr; 135(4):577-81. PubMed ID: 323377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal immunization with P fimbriae for the prevention of neonatal pyelonephritis.
    Kaack MB; Roberts JA; Baskin G; Patterson GM
    Infect Immun; 1988 Jan; 56(1):1-6. PubMed ID: 2891616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of pyelonephritis in the primate model. V. Effect of superoxide dismutase.
    Roberts JA; Roth JK; Domingue G; Lewis RW; Kaack B; Baskin G
    J Urol; 1982 Dec; 128(6):1394-400. PubMed ID: 6759691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of pyelonephritis in the primate model. VI. Effect of complement depletion.
    Roberts JA; Roth JK; Domingue G; Lewis RW; Kaack B; Baskin G
    J Urol; 1983 Jan; 129(1):193-6. PubMed ID: 6338249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
    Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
    J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host response to porcine strains of Escherichia coli in a novel pyelonephritis model.
    Isling LK; Aalbæk B; Birck MM; Heegaard PM; Leifsson PS
    J Comp Pathol; 2011 May; 144(4):257-68. PubMed ID: 21159351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local immunie response in experimental pyelonephritis in the rabbit. III. Lymphocyte responsivieness to O and K antigens of Escherichia coli.
    Smith JW; Kaijser B
    Immunology; 1976 Aug; 31(2):233-7. PubMed ID: 783043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of pyelonephritis by immunization with P-fimbriae.
    Roberts JA; Hardaway K; Kaack B; Fussell EN; Baskin G
    J Urol; 1984 Mar; 131(3):602-7. PubMed ID: 6199527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and fate of Escherichia coli in hematogenous pyelonephritis.
    SANFORD JP; HUNTER BW; DONALDSON P
    J Exp Med; 1962 Sep; 116(3):285-94. PubMed ID: 14496913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pyelonephritis. Electron microscopic study. II. Persistence of variant bacterial forms.
    Smith TW; Roberts JA
    Invest Urol; 1978 Sep; 16(2):154-62. PubMed ID: 361629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria.
    Ahlstedt S; Kaijser B
    Immunology; 1975 May; 28(5):841-6. PubMed ID: 1093966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis.
    Yagmurlu A; Boleken ME; Ertoy D; Ozsan M; Gokcora IH; Dindar H
    Urology; 2003 May; 61(5):1037-41. PubMed ID: 12736043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant effect on renal scarring following infection of mannose-sensitive-piliated bacteria.
    Matsumoto T; Mitzunoe Y; Ogata N; Tanaka M; Takahashi K; Kumazawa J
    Nephron; 1992; 60(2):210-5. PubMed ID: 1348108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.